LAMEA Cancer Biomarkers Market Size, Share & Industry Trends Analysis Report By Profiling Technologies, By Application, By Type, By Cancer Type, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Cancer Biomarkers Market would witness Market growth of 23.4% CAGR during the forecast period (2022-2028).

In oncology, biomarkers are substances secreted by a tumor or a distinct human body reaction that indicate the existence of cancer. Using diverse genomes and proteomics technologies, biomarkers enable early cancer detection and ease high-speed non-invasive diagnosis. Biomarkers are employed in a variety of applications, including cancer diagnosis, medication research, prognostics, and customized medicine. In addition, the growing demand for biomarkers in medication research and development for personalized medicine is propelling the Market forward.

Research and development in cancer biomarkers is aided by funding from various government & private organizations. Increasing investment in cancer biomarker research and development is a priority for a number of government and corporate organizations. This is due to the rising global incidence and prevalence of cancer.

Cancer is a significant public health concern that affects people all across the world. It is one of the top causes of death in a number of regions, depending on individual differences. Socioeconomic, ethnic, racial, and cultural characteristics differ across low and high-income countries, resulting in inequities.

According to data from the International Agency for Research on Cancer's (IARC) GLOBOCAN 2018 database, the estimated results of 36 cancer types available from 47 countries in WHO's African region (AFRO) revealed that 811,200 new cancer cases (4.5% of the total world) and 534,000 cancer deaths (7.3% of the total world) were reported in AFRO countries in 2018. The estimated cancer burden in AFRO countries is mostly due to breast cancer, which accounts for 27.7% of all cancer cases, trailed by cervical cancer, which accounts for 19.6% of all cases. When taken as a whole, this is the most prevalent in African girls.

The Brazil Market dominated the LAMEA Cancer Biomarkers Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $765.9 million by 2028. The Argentina Market is estimated to grow at a CAGR of 24.1% during (2022 - 2028). Additionally, The UAE Market would showcase a CAGR of 23.1% during (2022 - 2028).

Based on Profiling Technologies, the Market is segmented into Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, and Cytogenetics. Based on Application, the Market is segmented into Diagnostics, Research & Development, Prognostics, Risk Assessment, and Others. Based on Type, the Market is segmented into Protein, Genetic, and Others. Based on Cancer Type, the Market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Thyroid Cancer, Melanoma & Leukemia, Kidney & Bladder Cancer, Non-Hodgkin's Lymphoma, Prostate Cancer, and Others. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Cancer Biomarkers Market is Predict to reach $34.3 Billion by 2028, at a CAGR of 16.8%

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Agilent Technologies, Inc., and Merck & Co., Inc.

Scope of the Study

Market Segments Covered in the Report:

By Profiling Technologies

• Omics Technologies
• Imaging Technologies
• Immunoassay
• Bioinformatics
• Cytogenetics

By Application

• Diagnostics
• Research & Development
• Prognostics
• Risk Assessment
• Others

By Type

• Protein
• Genetic
• Others

By Cancer Type

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Thyroid Cancer
• Melanoma & Leukemia
• Kidney & Bladder Cancer
• Non-Hodgkin's Lymphoma
• Prostate Cancer
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• BioMérieux S.A.
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Agilent Technologies, Inc.
• Merck & Co., Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cancer Biomarkers Market, by Profiling Technologies
1.4.2 LAMEA Cancer Biomarkers Market, by Application
1.4.3 LAMEA Cancer Biomarkers Market, by Type
1.4.4 LAMEA Cancer Biomarkers Market, by Cancer Type
1.4.5 LAMEA Cancer Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Cancer Biomarkers Market

Chapter 4. LAMEA Cancer Biomarkers Market by Profiling Technologies
4.1 LAMEA Omics Technologies Market by Country
4.2 LAMEA Imaging Technologies Market by Country
4.3 LAMEA Immunoassay Market by Country
4.4 LAMEA Bioinformatics Market by Country
4.5 LAMEA Cytogenetics Market by Country

Chapter 5. LAMEA Cancer Biomarkers Market by Application
5.1 LAMEA Diagnostics Market by Country
5.2 LAMEA Research & Development Market by Country
5.3 LAMEA Prognostics Market by Country
5.4 LAMEA Risk Assessment Market by Country
5.5 LAMEA Others Market by Country

Chapter 6. LAMEA Cancer Biomarkers Market by Type
6.1 LAMEA Protein Market by Country
6.2 LAMEA Genetic Market by Country
6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Cancer Biomarkers Market by Cancer Type
7.1 LAMEA Breast Cancer Market by Country
7.2 LAMEA Lung Cancer Market by Country
7.3 LAMEA Colorectal Cancer Market by Country
7.4 LAMEA Thyroid Cancer Market by Country
7.5 LAMEA Melanoma & Leukemia Market by Country
7.6 LAMEA Kidney & Bladder Cancer Market by Country
7.7 LAMEA Non-Hodgkin's Lymphoma Market by Country
7.8 LAMEA Prostate Cancer Market by Country
7.9 LAMEA Others Market by Country

Chapter 8. LAMEA Cancer Biomarkers Market by Country
8.1 Brazil Cancer Biomarkers Market
8.1.1 Brazil Cancer Biomarkers Market by Profiling Technologies
8.1.2 Brazil Cancer Biomarkers Market by Application
8.1.3 Brazil Cancer Biomarkers Market by Type
8.1.4 Brazil Cancer Biomarkers Market by Cancer Type
8.2 Argentina Cancer Biomarkers Market
8.2.1 Argentina Cancer Biomarkers Market by Profiling Technologies
8.2.2 Argentina Cancer Biomarkers Market by Application
8.2.3 Argentina Cancer Biomarkers Market by Type
8.2.4 Argentina Cancer Biomarkers Market by Cancer Type
8.3 UAE Cancer Biomarkers Market
8.3.1 UAE Cancer Biomarkers Market by Profiling Technologies
8.3.2 UAE Cancer Biomarkers Market by Application
8.3.3 UAE Cancer Biomarkers Market by Type
8.3.4 UAE Cancer Biomarkers Market by Cancer Type
8.4 Saudi Arabia Cancer Biomarkers Market
8.4.1 Saudi Arabia Cancer Biomarkers Market by Profiling Technologies
8.4.2 Saudi Arabia Cancer Biomarkers Market by Application
8.4.3 Saudi Arabia Cancer Biomarkers Market by Type
8.4.4 Saudi Arabia Cancer Biomarkers Market by Cancer Type
8.5 South Africa Cancer Biomarkers Market
8.5.1 South Africa Cancer Biomarkers Market by Profiling Technologies
8.5.2 South Africa Cancer Biomarkers Market by Application
8.5.3 South Africa Cancer Biomarkers Market by Type
8.5.4 South Africa Cancer Biomarkers Market by Cancer Type
8.6 Nigeria Cancer Biomarkers Market
8.6.1 Nigeria Cancer Biomarkers Market by Profiling Technologies
8.6.2 Nigeria Cancer Biomarkers Market by Application
8.6.3 Nigeria Cancer Biomarkers Market by Type
8.6.4 Nigeria Cancer Biomarkers Market by Cancer Type
8.7 Rest of LAMEA Cancer Biomarkers Market
8.7.1 Rest of LAMEA Cancer Biomarkers Market by Profiling Technologies
8.7.2 Rest of LAMEA Cancer Biomarkers Market by Application
8.7.3 Rest of LAMEA Cancer Biomarkers Market by Type
8.7.4 Rest of LAMEA Cancer Biomarkers Market by Cancer Type

Chapter 9. Company Profiles
9.1 BioMérieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Qiagen N.V.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Product Launches and Product Expansions:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Merck & Co., Inc. (Merck Millipore)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses

TABLE 1 LAMEA Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 4 LAMEA Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 5 LAMEA Omics Technologies Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Omics Technologies Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Imaging Technologies Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Imaging Technologies Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Bioinformatics Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Bioinformatics Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Cytogenetics Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Cytogenetics Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 16 LAMEA Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 17 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Research & Development Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Research & Development Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Prognostics Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Prognostics Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Risk Assessment Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Risk Assessment Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 28 LAMEA Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 29 LAMEA Protein Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Protein Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Genetic Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Genetic Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 36 LAMEA Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 37 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Colorectal Cancer Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Colorectal Cancer Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA Thyroid Cancer Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Thyroid Cancer Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Melanoma & Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Melanoma & Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 47 LAMEA Kidney & Bladder Cancer Market by Country, 2018 - 2021, USD Million
TABLE 48 LAMEA Kidney & Bladder Cancer Market by Country, 2022 - 2028, USD Million
TABLE 49 LAMEA Non-Hodgkin's Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 50 LAMEA Non-Hodgkin's Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 51 LAMEA Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 52 LAMEA Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 53 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 54 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 55 LAMEA Cancer Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 56 LAMEA Cancer Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 57 Brazil Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 58 Brazil Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 59 Brazil Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 60 Brazil Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 61 Brazil Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 62 Brazil Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 63 Brazil Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 64 Brazil Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 65 Brazil Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 66 Brazil Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 67 Argentina Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 68 Argentina Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 69 Argentina Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 70 Argentina Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 71 Argentina Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 72 Argentina Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 73 Argentina Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 74 Argentina Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 75 Argentina Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 76 Argentina Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 77 UAE Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 78 UAE Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 79 UAE Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 80 UAE Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 81 UAE Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 82 UAE Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 83 UAE Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 84 UAE Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 85 UAE Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 86 UAE Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 87 Saudi Arabia Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 88 Saudi Arabia Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 89 Saudi Arabia Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 90 Saudi Arabia Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 91 Saudi Arabia Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 92 Saudi Arabia Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 93 Saudi Arabia Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 94 Saudi Arabia Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 95 Saudi Arabia Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 96 Saudi Arabia Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 97 South Africa Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 98 South Africa Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 99 South Africa Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 100 South Africa Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 101 South Africa Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 102 South Africa Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 103 South Africa Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 104 South Africa Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 105 South Africa Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 106 South Africa Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 107 Nigeria Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 108 Nigeria Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 109 Nigeria Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 110 Nigeria Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 111 Nigeria Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 112 Nigeria Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 113 Nigeria Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 114 Nigeria Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 115 Nigeria Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 116 Nigeria Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 117 Rest of LAMEA Cancer Biomarkers Market, 2018 - 2021, USD Million
TABLE 118 Rest of LAMEA Cancer Biomarkers Market, 2022 - 2028, USD Million
TABLE 119 Rest of LAMEA Cancer Biomarkers Market by Profiling Technologies, 2018 - 2021, USD Million
TABLE 120 Rest of LAMEA Cancer Biomarkers Market by Profiling Technologies, 2022 - 2028, USD Million
TABLE 121 Rest of LAMEA Cancer Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 122 Rest of LAMEA Cancer Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 123 Rest of LAMEA Cancer Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 124 Rest of LAMEA Cancer Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 125 Rest of LAMEA Cancer Biomarkers Market by Cancer Type, 2018 - 2021, USD Million
TABLE 126 Rest of LAMEA Cancer Biomarkers Market by Cancer Type, 2022 - 2028, USD Million
TABLE 127 Key information – BioMérieux S.A.
TABLE 128 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 129 Key information – Becton, Dickinson and Company
TABLE 130 Key Information – Abbott Laboratories
TABLE 131 Key Information – Thermo Fisher Scientific, Inc.
TABLE 132 key information – Illumina, Inc.
TABLE 133 Key Information – Bio-Rad Laboratories, Inc.
TABLE 134 Key Information – Qiagen N.V.
TABLE 135 key Information – Agilent Technologies, Inc.
TABLE 136 KEY INFORMATION - MERCK & CO., INC.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 3 Swot analysis: thermo fisher scientific, inc.